Cromos Pharma

Cromos Pharma is an international research organization (CRO) specializing in clinical trials. Find out more by visiting www.cromospharma.com.

Established in 2004, Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 15 years' experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

04/01/2026

Cromos Pharma is currently seeking a Clinical Project Manager to join our team.

Location: Europe

For additional details about this exciting opportunity, please visit our website: https://cromospharma.com/clinical-project-manager/

If you're ready to take the next step in your career with Cromos Pharma, kindly send your CV to cv@cromospharma.com

03/31/2026

Warmest Passover greetings from everyone at Cromos Pharma!

May this meaningful season fill your days with joy, warmth, and time well spent with those who matter most. We celebrate the spirit of unity and resilience that Passover embodies.

Chag Sameach!

03/20/2026

Eid Mubarak!

As the holy month of Ramadan comes to an end, we extend our warmest wishes for peace, joy, and prosperity. May this special celebration bring happiness, unity, and blessings to you and your loved ones.

03/18/2026

We’re pleased to share that Nicole Brenna, U.S. Business Development Director at Cromos Pharma, will be attending the AACR Annual Meeting 2026.

The AACR Annual Meeting is one of the most influential global oncology conferences, bringing together leading experts in cancer research, clinical development, translational science, and innovative therapies to accelerate progress in oncology.

Nicole looks forward to connecting with industry peers, exchanging insights, and discussing how Cromos Pharma can support oncology and complex clinical development programs.

If you’ll be attending AACR 2026 and would like to schedule a meeting, please reach out to inquiry@cromospharma.com

03/16/2026

Cromos Pharma is currently seeking a Head of Quality Management to join our team.

Location: Worlwide

For additional details about this exciting opportunity, please visit our website: https://cromospharma.com/head-of-quality-management/

If you're ready to take the next step in your career with Cromos Pharma, kindly send your CV to cv@cromospharma.com

03/03/2026

From Protocol Concept to Cost Clarity in Minutes

For biotech executives, early clinical budgeting is not about precision — it’s about direction, speed, and strategic optionality.

Before NDAs, CRO engagement, or lengthy feasibility cycles, you need clarity:

∙ What will this study likely cost?
∙ How does geography shift the budget profile?
∙ How do enrollment speed, monitoring intensity, and duration affect projections?

That’s why we developed the AI-Powered Clinical Trial Budget Calculator.
In minutes, model countries, site count, enrollment targets, monitoring intensity, and study duration — and instantly see how each variable impacts projected costs. Compare scenarios and generate a clean PDF for board or investor discussions.

This is not a quote.
It’s directional intelligence for executive decision-making.

No waiting. No spreadsheets. No commitments.

Explore the calculator here:https://cromospharma.com/expertise/calculator/

03/02/2026

Cromos Pharma is currently seeking a Senior Clinical Research Associate to join our team.

Location: USA

For additional details about this exciting opportunity, please visit our website: https://lnkd.in/dXgi99MH

If you're ready to take the next step in your career with Cromos Pharma, kindly send your CV to cv@cromospharma.com

,

02/26/2026

Ahead of Rare Disease Day on February 28, 2026, one reality stands out: rare diseases are no longer a niche in pharma.

With half of 2025 FDA approvals carrying orphan designation and pricing, regulatory and access pressures intensifying, rare disease programs are redefining how pharmaceutical value is created.

What does this shift mean for strategy in 2026? Read the full analysis here: https://cromospharma.com/rare-disease-day-2026-a-new-economic-reality-for-pharma/?preview_id=11286&preview_nonce=9bb5e4a24d&_thumbnail_id=11287&preview=true

02/19/2026

The FDA’s rejection of Regenxbio’s gene therapy for Hunter syndrome is more than a single setback. It signals a shift in regulatory expectations for the entire AAV field.

Durability. Clinically meaningful endpoints. Manufacturing robustness. The bar is rising and regulatory risk now weighs as heavily as scientific risk.

What does this mean for gene therapy sponsors and biotech leaders? Read more: https://cromospharma.com/fda-rejects-regenxbio-s-hunter-syndrome-gene-therapy-a-turning-point-for-the-aav-field/?preview_id=11222&preview_nonce=897a022f41&_thumbnail_id=11224&preview=true

02/17/2026

Happy Year of the Horse!

Wishing you a year filled with strength, momentum, and bold achievements. May this lunar cycle bring dynamic growth, new opportunities, and continued success in everything you do.

02/10/2026

SCOPE 2026 made one thing clear: clinical research is moving from experimentation to ex*****on.

From digital protocols and production-ready AI to real site enablement and continuous patient recruitment, the industry is no longer asking if change is coming, but how fast it can scale.

In this article, Nicole Brenna, US Business Development Director at Cromos Pharma, shares key takeaways from SCOPE 2026 and explains how these shifts are already reshaping trial design, operations, and decision-making across sponsors and CROs.

Read the full article here: https://cromospharma.com/why-scope-2026-felt-different-for-clinical-research/?preview_id=11125&preview_nonce=3af800ffd7&_thumbnail_id=11127&preview=true

02/05/2026

Cromos Pharma is on the ground at SCOPE 2026.

Our Business Development Director, Nicole Brenna, is representing Cromos Pharma in Orlando this week meeting with sponsors, reconnecting with partners, and engaging in meaningful conversations about where clinical development is heading next.

SCOPE is always about more than trends. It is about ex*****on, accountability, and what truly works in clinical trials.

If you are here too, let’s connect:inquiry@cromospharma.com

Address

US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150
Portland, OR
97204

Telephone

+15034443463

Website

http://www.cromospharma.com/

Alerts

Be the first to know and let us send you an email when Cromos Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Portland?